Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chemocentryx Inc (CCXI)

Chemocentryx Inc (CCXI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 463,804
  • Shares Outstanding, K 58,048
  • Annual Sales, $ 42,880 K
  • Annual Income, $ -37,970 K
  • 60-Month Beta 1.15
  • Price/Sales 10.36
  • Price/Cash Flow N/A
  • Price/Book 6.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.28
  • Number of Estimates 5
  • High Estimate -0.26
  • Low Estimate -0.32
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.44 +20.19%
on 09/30/19
8.18 -5.36%
on 10/18/19
+0.49 (+6.76%)
since 09/18/19
3-Month
6.16 +25.65%
on 08/06/19
8.43 -8.19%
on 09/12/19
-0.54 (-6.52%)
since 07/18/19
52-Week
6.16 +25.65%
on 08/06/19
14.98 -48.33%
on 04/05/19
-3.95 (-33.79%)
since 10/18/18

Most Recent Stories

More News
Chemocentryx Inc Rises 1.37% on Heavy Volume: Watch For Potential Pullback

Chemocentryx Inc (NASDAQ:CCXI) traded in a range yesterday that spanned from a low of $7.31 to a high of $7.51. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of...

CCXI : 7.74 (-3.13%)
ChemoCentryx to Host R&D Day on October 1, 2019

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that it will host an R&D Day on Tuesday, October 1, 2019 beginning at 12:00 p.m. ET in New York City.

CCXI : 7.74 (-3.13%)
Ligand Pharm is Among the Companies in the Biotechnology Industry with the Best Relative Performance (LGND , CCXI , ALXN , VNDA , UTHR )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ALXN : 98.41 (-1.58%)
CCXI : 7.74 (-3.13%)
LGND : 105.93 (-2.08%)
Chemocentryx Inc Down 46.3% Since SmarTrend Downtrend Call (CCXI)

SmarTrend identified a Downtrend for Chemocentryx Inc (NASDAQ:CCXI) on April 15th, 2019 at $12.97. In approximately 5 months, Chemocentryx Inc has returned 46.32% as of today's recent price of $6.96.

CCXI : 7.74 (-3.13%)
Chemocentryx Inc Down 48.6% Since SmarTrend Downtrend Call (CCXI)

SmarTrend identified a Downtrend for Chemocentryx Inc (NASDAQ:CCXI) on April 15th, 2019 at $12.97. In approximately 5 months, Chemocentryx Inc has returned 48.55% as of today's recent price of $6.67.

CCXI : 7.74 (-3.13%)
ChemoCentryx to Present at Two Upcoming Investor Conferences

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences in September:

CCXI : 7.74 (-3.13%)
Downtrend Call Working As Chemocentryx Inc Stock Falls 45.1% (CCXI)

SmarTrend identified a Downtrend for Chemocentryx Inc (NASDAQ:CCXI) on April 15th, 2019 at $12.97. In approximately 4 months, Chemocentryx Inc has returned 45.08% as of today's recent price of $7.12.

CCXI : 7.74 (-3.13%)
Chemocentryx Inc Shares Down 46.9% Since SmarTrend's Sell Call (CCXI)

SmarTrend identified a Downtrend for Chemocentryx Inc (NASDAQ:CCXI) on April 15th, 2019 at $12.97. In approximately 4 months, Chemocentryx Inc has returned 46.93% as of today's recent price of $6.88.

CCXI : 7.74 (-3.13%)
ChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue Estimates

ChemoCentryx (CCXI) delivered earnings and revenue surprises of -23.81% and -28.86%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

CCXI : 7.74 (-3.13%)
ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights

-- Topline data from pivotal ADVOCATE Phase III trial of C5a receptor inhibitor avacopan in ANCA Vasculitis on track for Q4 2019 --

CCXI : 7.74 (-3.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade CCXI with:

Business Summary

ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.

See More

Key Turning Points

2nd Resistance Point 8.35
1st Resistance Point 8.05
Last Price 7.74
1st Support Level 7.57
2nd Support Level 7.39

See More

52-Week High 14.98
Fibonacci 61.8% 11.61
Fibonacci 50% 10.57
Fibonacci 38.2% 9.53
Last Price 7.74
52-Week Low 6.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar